MSCRF Validation Program RFA Grant

MSCRF Validation Program RFA Grant

Status: ACTIVE
Funder: Maryland Stem Cell Research Fund
Amount: Up to US $250,000
Last Updated: November 13, 2025

Summary

The Maryland Stem Cell Research Fund (MSCRF) Validation Program aims to accelerate the transition of innovative stem cell technologies from research labs to the commercial sector. With funding of up to $250,000, the program supports projects that address unmet medical needs, fosters collaborations between academic and private sectors, and emphasizes the development of new medical strategies for human diseases. This initiative is vital for advancing stem cell research and enhancing healthcare outcomes in Maryland.

Overview

NOTE: Principal Investigators are encouraged to register in the TEDCO online submission system at least one month before the Application Submission Deadline. Maryland Stem Cell Research Fund Mission Develop new medical strategies for the prevention, diagnosis, treatment and cure of human diseases, injuries and conditions through human stem cells. Purpose The purpose of the Fund is to promote state-funded stem cell research and cures through grants and loans to public and private entities in the state. Validation Program Stem cell research offers extraordinary promise for new medical therapies and a better understanding of the devastating diseases of our time. The development of new medical strategies for the prevention, diagnosis, treatment and cure of human diseases, injuries and conditions through human stem cell research is a high priority for the State of Maryland. Funding Objectives The Maryland Stem Cell Research Fund (MSCRF) Validation Program was created to foster the transition of promising stem cell technologies having significant commercial potential from universities and research labs where they were discovered, to the commercial sector, where they can be developed into products and services that meet identified market needs . The Validation Program is designed to promote the commercialization of stem cell-based technologies for unmet medical needs. This is achieved through validation, market assessment, and facilitating the licensing of technologies to a commercial entity. It is also the intent of the Program to foster collaborations between various schools, departments, and institutions within academic research organizations, and between public and private sectors. With a strategic goal to enhance collaboration between academic institutions and businesses in Maryland, the program provides an opportunity to access supplementary funding (“Second-tier Funding”) for advancing technology development, particularly in cases where there is potential for collaboration between an academic institution and a commercial entity. Award Information Subject to meeting the Program requirements, an award not to exceed $250,000 may be made for a project. Funded Projects must be completed within 24 months of the date of execution of the award. Applicants should not expect approvals of any no-cost extensions and should plan accordingly.

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.